Michael Vance Molyneaux
Directeur Technique/Scientifique/R&D chez Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Fortune : - $ au 30/04/2024
Profil
Michael Vance Molyneaux is currently the Executive Director & Chief Medical Officer at Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
He previously worked as the Medical Director at The Passavant Memorial Area Hospital Association from 2008 to 2013 and as the Chief Medical Officer at Macrocure Ltd.
(United States).
He also served as the Executive Director & Chief Medical Officer at Sirnaomics Ltd.
from 2021 to 2023.
Dr. Molyneaux holds a graduate degree from Washington University in St. Louis, a doctorate from Dalhousie University, and an undergraduate degree from the University of Prince Edward Island.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SIRNAOMICS LTD.
-.--% | 30/11/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Michael Vance Molyneaux
Sociétés | Poste | Début |
---|---|---|
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Michael Vance Molyneaux
Sociétés | Poste | Fin |
---|---|---|
SIRNAOMICS LTD. | Directeur Technique/Scientifique/R&D | 30/11/2023 |
The Passavant Memorial Area Hospital Association
The Passavant Memorial Area Hospital Association Medical/Nursing ServicesHealth Services The Passavant Memorial Area Hospital Association provides health care services. Its services include surgery, behavioral health, cardiac, laboratory, wound care, telehealth, and rehabilitation. The company was founded in 1875 and is headquartered in Jacksonville, IL. | Corporate Officer/Principal | 01/01/2013 |
Macrocure Ltd. (United States) | Directeur Technique/Scientifique/R&D | - |
Formation de Michael Vance Molyneaux
University of Prince Edward Island | Undergraduate Degree |
Dalhousie University | Doctorate Degree |
Washington University in St. Louis | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SIRNAOMICS LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Health Technology |
The Passavant Memorial Area Hospital Association
The Passavant Memorial Area Hospital Association Medical/Nursing ServicesHealth Services The Passavant Memorial Area Hospital Association provides health care services. Its services include surgery, behavioral health, cardiac, laboratory, wound care, telehealth, and rehabilitation. The company was founded in 1875 and is headquartered in Jacksonville, IL. | Health Services |
Macrocure Ltd. (United States) |